156-Engineering Myeloid Cells for Cancer Immunotherapy

This paper discusses the emerging field of engineering myeloid cells, specifically macrophages, for cancer immunotherapy. It begins by contrasting the promising but challenging Chimeric Antigen Receptor T-cell (CAR-T) therapies, which face issues like toxicity and limited efficacy against solid tumors, with alternative approaches like CAR-Natural Killer (CAR-NK) cells and CAR-macrophages (CAR-Ms)....去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动